Pitavastatin impurity standards
30 characterised compounds linked to Pitavastatin are catalogued here, from named pharmacopoeial impurities to synthesis intermediates and breakdown products. Highlights of the range are 3 metabolites or hydroxylated analogues and 2 degradation products.
Batches are supplied with a certificate of analysis, and the supporting spectra can be sent ahead of a purchase order so your QA team can review them. Typical uses are method development and validation, relative response factor work, forced degradation studies and the impurity sections of ANDA, DMF or CEP filings.
By impurity type
Counts are based on product names. One compound can fall into more than one type.
All Pitavastatin reference materials
- CAS
- 1187966-93-3
- Formula
- C25H22FNO4
- MW
- 419.4 g/mol
- CAS
- 1809100-36-4
- Formula
- C25H22FNO4
- MW
- 419.4 g/mol
- CAS
- 148516-15-8
- Formula
- C25H20FNO2
- MW
- 385.4 g/mol
- CAS
- 2245811-13-4
- Formula
- C25H20FNO3
- MW
- 401.4 g/mol
- CAS
- 154057-58-6
- Formula
- C37H30BrFNP
- MW
- 618.5 g/mol
- CAS
- 154057-56-4
- Formula
- C19H15BrFN
- MW
- 356.2 g/mol
- CAS
- 121660-37-5
- Formula
- C19H14FNO
- MW
- 291.3 g/mol
- CAS
- 1187966-91-1
- Formula
- C25H24FNO4
- MW
- 421.5 g/mol
- CAS
- 154026-94-5
- Formula
- C13H23ClO4
- MW
- 278.77 g/mol